Côte d'Ivoire vs Kuwait: Access to anti-retroviral drugs, male
Côte d'Ivoire
69.0%
in 2024
Kuwait
71.0%
in 2024
Côte d'Ivoire rank
72nd
Kuwait rank
69th
Access to anti-retroviral drugs, male over time
- Côte d'Ivoire
- Kuwait
How they compare
Kuwait currently reports 71.0% against 69.0% in Côte d'Ivoire, a difference of 2.0%.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Kuwait ahead.
Côte d'Ivoire ranks 72nd and Kuwait ranks 69th of 141 countries.
Across the 3 decades both report, Côte d'Ivoire averaged higher in 1 and Kuwait in 2.
Head to head by decade
| Decade | Côte d'Ivoire | Kuwait | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 3.4% | 38.4% | 35.0% | Kuwait |
| 2010s | 28.6% | 35.4% | 6.8% | Kuwait |
| 2020s | 61.2% | 55.8% | 5.4% | Côte d'Ivoire |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Côte d'Ivoire or Kuwait?
- Kuwait, at 71.0% against 69.0% in Côte d'Ivoire as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Côte d'Ivoire and Kuwait?
- 2.0%, with Kuwait ahead.
- How many years of comparable data are there for Côte d'Ivoire and Kuwait?
- 25 years are reported by both, from 2000 to 2024.
- How do Côte d'Ivoire and Kuwait rank globally for access to anti-retroviral drugs, male?
- Côte d'Ivoire ranks 72nd and Kuwait ranks 69th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.